Back
Atara Biotherapeutics Stock Predictions
Sponsored
ATRA
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
8.03
Seasonality Move:
-9.83%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Atara Biotherapeutics Stock Forecast
- Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 19.2% based on the past 9 years of stock performance.
- Atara Biotherapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Atara Biotherapeutics Stock Undervalued?
The current Atara Biotherapeutics [ATRA] share price is $8.08. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - ATRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Atara Biotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 19.2% based on the past 9 years of stock performance.
Atara Biotherapeutics Stock Rating
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics overpriced?
- Atara Biotherapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Atara Biotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com
52-Week Data
52-Week High:
45.75
52-Week Low:
4.97
Prediction Charts
Market Cap:
45.82M
Price in USD:
8.08
Volume:
106.76K
Beta:
0.95
Technical Analysis
SMA50:
8.33
SMA100:
10.28
SMA200:
13.79
52-Wk Change:
-78.75%
Stock Predictions
-
Is Atara Biotherapeutics stock public?
Yes, Atara Biotherapeutics is a publicly traded company. -
What is the Atara Biotherapeutics stock quote today?
The Atara Biotherapeutics stock price is 8.08 USD today. -
How to buy Atara Biotherapeutics stock online?
You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-10 | 8.95 | 8.59 | 9.33 | 8.57 |
Sep-11 | 8.60 | 8.32 | 8.85 | 8.03 |
Sep-12 | 8.40 | 8.09 | 8.50 | 8.02 |
Sep-13 | 8.11 | 9.72 | 9.81 | 8.11 |
Sep-16 | 9.13 | 8.60 | 9.49 | 8.60 |
Sep-17 | 8.77 | 8.51 | 9.12 | 8.51 |
Sep-18 | 8.55 | 7.89 | 8.80 | 7.85 |
Sep-19 | 8.08 | 7.93 | 8.34 | 7.77 |
Sep-20 | 8.00 | 7.79 | 8.11 | 7.60 |
Sep-23 | 7.87 | 7.36 | 7.95 | 7.35 |
Sep-24 | 7.51 | 7.55 | 7.60 | 7.10 |
Sep-25 | 7.70 | 7.40 | 7.70 | 7.25 |
Sep-26 | 7.56 | 7.66 | 7.68 | 7.26 |
Sep-27 | 7.72 | 8.08 | 8.39 | 7.61 |
Atara Biotherapeutics Earnings
Atara Biotherapeutics Earnings Report: Per Share Atara Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Atara Biotherapeutics Forecast Revenue Growth
Atara Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $8.28 per share, an increase this year of $42.84 per share, and a decrease next year of $64.80 per share.
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.